Literature DB >> 18064419

Presynaptic adenosine and P2Y receptors.

Jorge Gonçalves1, Glória Queiroz.   

Abstract

Adenine-based purines, such as adenosine and ATP, are ubiquitous molecules that, in addition to their roles in metabolism, act as modulators of neurotransmitter release through activation of presynaptic P1 purinoceptors or adenosine receptors (activated by adenosine) and P2 receptors (activated by nucleotides). Of the latter, the P2Y receptors are G protein-coupled, whereas the P2X receptors are ligand-gated ion channels and not covered in this review.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18064419     DOI: 10.1007/978-3-540-74805-2_11

Source DB:  PubMed          Journal:  Handb Exp Pharmacol        ISSN: 0171-2004


  4 in total

1.  P2Y1 receptor activation by photolysis of caged ATP enhances neuronal network activity in the developing olfactory bulb.

Authors:  Timo Fischer; Natalie Rotermund; Christian Lohr; Daniela Hirnet
Journal:  Purinergic Signal       Date:  2011-12-22       Impact factor: 3.765

2.  Histamine H3 receptor activation counteracts adenosine A2A receptor-mediated enhancement of depolarization-evoked [3H]-GABA release from rat globus pallidus synaptosomes.

Authors:  Guadalupe-Elide Morales-Figueroa; Ricardo Márquez-Gómez; Raúl González-Pantoja; Juan Escamilla-Sánchez; José-Antonio Arias-Montaño
Journal:  ACS Chem Neurosci       Date:  2014-06-11       Impact factor: 4.418

3.  Facilitation of transmitter release from rat sympathetic neurons via presynaptic P2Y(1) receptors.

Authors:  Giri K Chandaka; Isabella Salzer; Helmut Drobny; Stefan Boehm; Klaus W Schicker
Journal:  Br J Pharmacol       Date:  2011-11       Impact factor: 8.739

4.  Pivotal Role of Adenosine Neurotransmission in Restless Legs Syndrome.

Authors:  Sergi Ferré; César Quiroz; Xavier Guitart; William Rea; Arta Seyedian; Estefanía Moreno; Verònica Casadó-Anguera; Manuel Díaz-Ríos; Vicent Casadó; Stefan Clemens; Richard P Allen; Christopher J Earley; Diego García-Borreguero
Journal:  Front Neurosci       Date:  2018-01-08       Impact factor: 4.677

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.